Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.

Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM.

Am J Gastroenterol. 2006 Jul;101(7):1581-90.

PMID:
16863564
2.

Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.

O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM.

Gastroenterology. 2005 Mar;128(3):541-51.

PMID:
15765388
3.

Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial.

Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK.

J Gastroenterol. 1997 Dec;32(6):765-8.

PMID:
9430014
4.

Spasmocanulase in irritable bowel syndrome.

Mohamed AE, Ghandour ZM, Al-Karawi MA.

Saudi Med J. 2002 Sep;23(9):1074-7.

PMID:
12370715
5.

Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.

Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME.

Am J Gastroenterol. 1996 Aug;91(8):1579-85.

PMID:
8759665
6.

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group.

N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409.

7.

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

Staudacher HM, Whelan K, Irving PM, Lomer MC.

J Hum Nutr Diet. 2011 Oct;24(5):487-95. doi: 10.1111/j.1365-277X.2011.01162.x. Epub 2011 May 25.

PMID:
21615553
8.

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD003460. doi: 10.1002/14651858.CD003460.pub3. Review.

PMID:
21833945
9.

British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults.

McKenzie YA, Alder A, Anderson W, Wills A, Goddard L, Gulia P, Jankovich E, Mutch P, Reeves LB, Singer A, Lomer MC; Gastroenterology Specialist Group of the British Dietetic Association.

J Hum Nutr Diet. 2012 Jun;25(3):260-74. doi: 10.1111/j.1365-277X.2012.01242.x. Epub 2012 Apr 10.

PMID:
22489905
11.

Herbal medicines for the management of irritable bowel syndrome: a comprehensive review.

Rahimi R, Abdollahi M.

World J Gastroenterol. 2012 Feb 21;18(7):589-600. doi: 10.3748/wjg.v18.i7.589. Review.

12.

Acupuncture for treatment of irritable bowel syndrome.

Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, Lao L.

Cochrane Database Syst Rev. 2012 May 16;(5):CD005111. doi: 10.1002/14651858.CD005111.pub3. Review.

13.

The role of diet in the pathogenesis and management of irritable bowel syndrome (Review).

El-Salhy M, Ostgaard H, Gundersen D, Hatlebakk JG, Hausken T.

Int J Mol Med. 2012 May;29(5):723-31. doi: 10.3892/ijmm.2012.926. Epub 2012 Feb 24. Review.

PMID:
22366773
14.

Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

Bixquert Jiménez M.

Rev Esp Enferm Dig. 2009 Aug;101(8):553-64. Review.

15.
16.

Complementary and alternative medicine for treatment of irritable bowel syndrome.

Shen YH, Nahas R.

Can Fam Physician. 2009 Feb;55(2):143-8. Review.

17.

The gut microbiota and irritable bowel syndrome: friend or foe?

Ghoshal UC, Shukla R, Ghoshal U, Gwee KA, Ng SC, Quigley EM.

Int J Inflam. 2012;2012:151085. doi: 10.1155/2012/151085. Epub 2012 Apr 22.

18.

Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.

Whelan K, Quigley EM.

Curr Opin Gastroenterol. 2013 Mar;29(2):184-9. doi: 10.1097/MOG.0b013e32835d7bba. Review.

PMID:
23286925
19.
20.

Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.

Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.

J Clin Gastroenterol. 2012 Oct;46 Suppl:S52-5. doi: 10.1097/MCG.0b013e318264e918.

PMID:
22955358

Supplemental Content

Support Center